Barclays Analysts Give Swiss Re (SREN) a CHF 97.70 Price Target
Several other equities analysts have also weighed in on SREN. Commerzbank set a CHF 95 price target on Swiss Re and gave the company a sell rating in a research note on Thursday, December 7th. UBS set a CHF 79 price target on Swiss Re and gave the company a sell rating in a research note on Wednesday, September 27th. Goldman Sachs Group set a CHF 95 price target on Swiss Re and gave the company a neutral rating in a research note on Thursday, December 7th. Morgan Stanley set a CHF 104.30 price target on Swiss Re and gave the company a buy rating in a research note on Wednesday, August 16th. Finally, Jefferies Group set a CHF 89 price target on Swiss Re and gave the company a neutral rating in a research note on Tuesday, November 28th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and eight have assigned a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of CHF 95.14.
Swiss Re (VTX:SREN) opened at CHF 91.45 on Monday. Swiss Re has a 12 month low of CHF 81.65 and a 12 month high of CHF 98.50.
WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/12/14/barclays-analysts-give-swiss-re-sren-a-chf-97-70-price-target.html.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Stock Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related stocks with our FREE daily email newsletter.